丹洛药片的作用机制是通过KEAP1介导的氧化死来影响MAFLD
Jingxuan Zhu1, Nan Song1, Jiaxin Wang1
1Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Journal of ethnopharmacology
|February 20, 2025
概括
丹卢片 (DLT) 显示了对代谢性脂肪肝疾病 (MAFLD) 的治疗潜力. 通过调节氧化亡路径,DLT增强了甘油三的分解,并减少了脂肪合成,提供了一种新的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 传统中国医药 传统中国医药
背景情况:
- 代谢性脂肪肝疾病 (MAFLD) 是动脉样硬化心血管疾病的重要危险因素.
- 丹卢片 (DLT) 是一种治疗冠状动脉疾病的传统中医药,显示了MAFLD的初步治疗潜力.
- 在治疗MAFLD中DLT的确切机制尚不清楚.
研究的目的:
- 为了确定DLT的活性成分,有效地对抗MAFLD.
- 通过体内和体外实验阐明DLT在治疗MAFLD中的分子机制.
主要方法:
- UPLC/ESI-Q TRAP-MS/MS分析DLT组成和血药理动力学.
- 建立一个MAFLD小鼠模型,使用高脂肪饮食,然后进行DLT治疗.
- 肝脏组织的组织病理学检查.
- 使用qRT-PCR,Western Blot和免疫光学评估氧化亡途径,新脂肪酸合成和甘油三代谢.
- 救援实验调查DLT对氧化亡途径的调节.
主要成果:
- 在DLT中发现了1003种化合物,其中109种在老鼠血中检测到;11种活性成分,包括Tanshinone IIA,被假定是关键的.
- 通过增加甘油三代谢和抑制体内和体外新脂肪酸合成,DLT显著降低了肝脂沉积.
- DLT恢复了蛋白激酶B的酸化,促进了甘油三代谢,并通过KEAP1/PGAM5/AIFM1氧化死途径抑制了新脂肪酸合成.
结论:
- DLT促进甘油三代谢,并抑制新的脂肪酸合成.
- DLT通过调节氧化亡途径来发挥其作用.
- DLT代表了改善MAFLD的潜在治疗策略.
关键词:
丹洛 (Danlou) 药片 丹洛 (Danlou) 药片 丹洛 (Danlou) 药片 丹洛 (Danlou) 药片KEAP1/PGAM5/AIFM1 的情况.代谢性脂肪肝疾病 (MAFLD) 是一种代谢性脂肪肝疾病.氧化性死症是什么?三糖的催化作用在 de novo 脂肪酸合成中.更多相关视频
05:28Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
Published on: June 2, 2023
731
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
6.8K
相关概念视频
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
Carrier-Mediated Transport
231
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
231
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Receptor-mediated Endocytosis
103.8K
Overview
103.8K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Membrane Asymmetry Regulating Transporters
4.3K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
4.3K
